-
Past, present, and future of Intestinal Research
- Jae Hee Cheon

-
Intest Res. 2023;21(1):1-2.
-
Perspective
Epub January 31, 2023
|
-
Use of device-assisted enteroscopy in small bowel disease: an expert consensus statement by the Korean Association for the Study of Intestinal Diseases
- Han Hee Lee
, Jin Su Kim , Hyeon Jeong Goong , et al.
-
Intest Res. 2023;21(1):3-19.
-
Statement
Epub January 31, 2023
|
-
Korean Guidelines for Postpolypectomy Colonoscopic Surveillance: 2022 revised edition
- Su Young Kim
, Min Seob Kwak , Soon Man Yoon , et al.
-
Intest Res. 2023;21(1):20-42.
-
Review
Epub January 31, 2023
|
-
Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease
- Seong-Joon Koh
, Sung Noh Hong , Soo-Kyung Park , et al.
-
Intest Res. 2023;21(1):43-60.
-
Review
Epub October 18, 2022
|
-
Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
- Soo-Young Na
, Chang Hwan Choi , Eun Mi Song , et al.
-
Intest Res. 2023;21(1):61-87.
-
Review
Epub May 31, 2022
|
-
Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis
- Katsuyoshi Matsuoka
, Kanae Togo , Noritoshi Yoshii , et al.
-
Intest Res. 2023;21(1):88-99.
-
Original Article
Epub March 11, 2022
|
-
Improvement of ulcerative colitis control by searching and restricting of inflammatory trigger factors in daily clinical practice
- Kun-Yu Tsai, Jeng-Fu You, Tzong-Yun Tsai, et al.
-
Intest Res. 2023;21(1):100-109.
-
Original Article
Epub November 14, 2022
|
-
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
- Toshifumi Hibi
, Satoshi Motoya , Tadakazu Hisamatsu , et al.
-
Intest Res. 2023;21(1):110-125.
-
Original Article
Epub March 11, 2022
|
-
Characteristics and usefulness of transabdominal ultrasonography in immune-mediated colitis
- Kensuke Sakurai
, Takehiko Katsurada , Mutsumi Nishida , et al.
-
Intest Res. 2023;21(1):126-136.
-
Original Article
Epub July 22, 2022
|
-
Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
- Kyunghwan Oh
, Hee Seung Hong , Nam Seok Ham , et al.
-
Intest Res. 2023;21(1):137-147.
-
Original Article
Epub July 12, 2022
|
-
Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease
- Seung Yong Shin
, Young Kim , Won-Seok Kim , et al.
-
Intest Res. 2023;21(1):148-160.
-
Original Article
Epub June 14, 2022
|
-
The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
- Jae Hee Cheon
, Kristine Paridaens , Sameer Al Awadhi , et al.
-
Intest Res. 2023;21(1):161-167.
-
Brief Communication
Epub April 18, 2022
|
-
The role and prospect of tofacitinib in patients with ulcerative colitis
- Jun Lee

-
Intest Res. 2023;21(1):168-169.
-
Letter to the Editor
Epub November 14, 2022
|